[go: up one dir, main page]

NO970517D0 - Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer - Google Patents

Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer

Info

Publication number
NO970517D0
NO970517D0 NO970517A NO970517A NO970517D0 NO 970517 D0 NO970517 D0 NO 970517D0 NO 970517 A NO970517 A NO 970517A NO 970517 A NO970517 A NO 970517A NO 970517 D0 NO970517 D0 NO 970517D0
Authority
NO
Norway
Prior art keywords
topical ophthalmic
treatment
ophthalmic formulations
formulations containing
ocular allergy
Prior art date
Application number
NO970517A
Other languages
English (en)
Other versions
NO311637B1 (no
NO970517L (no
Inventor
John Michael Yanni
Stella M Robertson
Eiji Hayakawa
Masashi Nakakura
Original Assignee
Alcon Lab Inc
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23864859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO970517(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Lab Inc, Kyowa Hakko Kogyo Kk filed Critical Alcon Lab Inc
Publication of NO970517D0 publication Critical patent/NO970517D0/no
Publication of NO970517L publication Critical patent/NO970517L/no
Publication of NO311637B1 publication Critical patent/NO311637B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19970517A 1995-06-06 1997-02-05 Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer NO311637B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,729 US5641805A (en) 1995-06-06 1995-06-06 Topical ophthalmic formulations for treating allergic eye diseases
PCT/US1996/006289 WO1996039147A2 (en) 1995-06-06 1996-05-03 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases

Publications (3)

Publication Number Publication Date
NO970517D0 true NO970517D0 (no) 1997-02-05
NO970517L NO970517L (no) 1997-04-03
NO311637B1 NO311637B1 (no) 2001-12-27

Family

ID=23864859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970517A NO311637B1 (no) 1995-06-06 1997-02-05 Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer

Country Status (20)

Country Link
US (1) US5641805A (no)
EP (1) EP0799044B1 (no)
JP (1) JP3068858B2 (no)
KR (1) KR100202155B1 (no)
CN (1) CN1082367C (no)
AT (1) ATE220906T1 (no)
AU (1) AU698854B2 (no)
CA (1) CA2195094C (no)
DE (2) DE10299034I2 (no)
DK (1) DK0799044T3 (no)
ES (1) ES2179198T3 (no)
FI (1) FI970489L (no)
LU (1) LU90969I2 (no)
MX (1) MX9701013A (no)
MY (1) MY116651A (no)
NL (1) NL300101I2 (no)
NO (1) NO311637B1 (no)
PT (1) PT799044E (no)
TW (1) TW438588B (no)
WO (1) WO1996039147A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
WO2000003705A1 (en) * 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
AU770975B2 (en) 1999-06-18 2004-03-11 Alcon Laboratories, Inc. Topical ophthalmic mast cell stabilizers for treating allergic eye diseases
CA2395866C (en) 2000-01-25 2009-10-13 Alcon, Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
AU5567501A (en) 2000-05-19 2001-12-03 Alcon Universal Ltd Disulfide derivatives useful for treating allergic diseases
AU5380701A (en) 2000-05-19 2001-12-03 Alcon Universal Ltd Compositions containing a benzamide disulfide derivative for treating allergic diseases
ATE272619T1 (de) 2000-05-19 2004-08-15 Alcon Inc Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
JP2004524375A (ja) * 2001-05-03 2004-08-12 ノバルティス アクチエンゲゼルシャフト 有機化合物の使用
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
PL369630A1 (en) * 2001-12-05 2005-05-02 Alcon, Inc. Use of a h1 antagonist and rimexolone as a safe steroid to treat rhinitis
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
CA2586553C (en) * 2004-11-24 2015-02-10 Alcon, Inc. Nasal sprayer containing a formulation with olopatadine
JP5315051B2 (ja) * 2005-07-08 2013-10-16 千寿製薬株式会社 オロパタジンを含む眼科用経皮吸収型製剤
BRPI0710085B8 (pt) 2006-03-31 2021-05-25 Vistakon Pharmaceutical Llc composições oftálmicas e seus kits
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
CA2677631C (en) 2007-02-07 2014-05-13 Alcon, Inc. Olopatadine formulations for topical nasal administration
CN101641094A (zh) * 2007-04-11 2010-02-03 爱尔康研究有限公司 TNFα抑制剂联合抗组胺药治疗变应性鼻炎和变应性结膜炎的用途
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
CA2698651A1 (en) 2007-09-06 2009-03-12 Kyowa Hakko Kirin Co., Ltd. Eye drop containing dibenz [b,e] oxepin derivative
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
IT1397503B1 (it) 2009-04-21 2013-01-16 F S I Fabbrica Italiana Sint Processo per la preparazione di olopatadina
CN102470099A (zh) * 2009-07-17 2012-05-23 爱尔康研究有限公司 儿童用奥洛他定鼻腔喷雾方案
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
BR112012007091A2 (pt) * 2009-10-01 2016-04-19 Alcon Res Ltd composições de olopatadina e seus usos
TW201206936A (en) 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN103202833A (zh) * 2012-12-25 2013-07-17 常州市亚邦医药研究所有限公司 一种奥洛他定或其盐的药用组合物及其制备方法
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
CN113985041A (zh) * 2021-09-29 2022-01-28 武汉钢铁有限公司 一种实验室检测设备精度控制的控制限的设定方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) * 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤

Also Published As

Publication number Publication date
DK0799044T3 (da) 2002-10-14
NL300101I2 (nl) 2003-01-06
DE10299034I1 (de) 2003-01-23
CA2195094A1 (en) 1996-12-12
DE69622527T2 (de) 2002-12-05
FI970489A0 (fi) 1997-02-05
LU90969I2 (fr) 2002-12-02
ES2179198T3 (es) 2003-01-16
MY116651A (en) 2004-03-31
KR100202155B1 (ko) 1999-06-15
AU698854B2 (en) 1998-11-12
FI970489A7 (fi) 1997-02-05
US5641805A (en) 1997-06-24
JPH09510235A (ja) 1997-10-14
KR970704452A (ko) 1997-09-06
WO1996039147A3 (en) 1997-02-20
AU5726196A (en) 1996-12-24
FI970489L (fi) 1997-02-05
CN1082367C (zh) 2002-04-10
ATE220906T1 (de) 2002-08-15
CN1161000A (zh) 1997-10-01
PT799044E (pt) 2002-11-29
JP3068858B2 (ja) 2000-07-24
EP0799044A2 (en) 1997-10-08
MX9701013A (es) 1997-05-31
EP0799044B1 (en) 2002-07-24
NO311637B1 (no) 2001-12-27
DE69622527D1 (de) 2002-08-29
NL300101I1 (nl) 2002-12-02
CA2195094C (en) 2002-02-26
NO970517L (no) 1997-04-03
TW438588B (en) 2001-06-07
DE10299034I2 (de) 2005-07-07
WO1996039147A2 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
NO970517L (no) Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer
CA2216796A1 (en) Quinazoline derivatives
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
CA2306393A1 (en) Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
CA2321560A1 (en) The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
AU5446299A (en) Medicinal compositions for treating eye diseases
WO2000018387A3 (en) Antibiotic compositions for treatment of the eye, ear and nose
AU8160194A (en) Ophthalmic suspension containing diflupredonate
NO980058L (no) Opthalmiske preparater
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
WO2000067738A3 (en) The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders
AU7587396A (en) Ocular depressor
WO1998038985A3 (en) Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
WO1999019324A3 (en) Antipsychotic substituted piperidine derivatives
AU2001270642A1 (en) Method for the treatment of glaucoma and ocular hypertension by administering nucleotides
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
WO2001082913A3 (en) Use of benzamide derivatives for the treatment of high ocular tension and glaucoma

Legal Events

Date Code Title Description
MK1K Patent expired